Discovery Of The First Non-Cgmp Mimetic Small Molecule Activators Of Cgmp-Dependent Protein Kinase 1 Alpha (Pkg1 Alpha)

PKG1 alpha is a central node in cGMP signaling. Current therapeutics that look to activate this pathway rely on elevation of cGMP levels and subsequent activation of PKG1 alpha. Direct activation of PKG1 alpha could potentially drive additional efficacy without associated side effects of blanket cGMP elevation. We undertook a high-throughput screen to identify novel activators. After triaging through numerous false positive hits, attributed to compound mediated oxidation and activation of PKG1 alpha, a piperidine series of compounds was validated. The hit 1 was a weak activator with EC50 = 47 mu M. The activity could be improved to single digit micromolar, as seen in compounds 21 and 25 (7.0 and 3.7 mu M respectively). Several compounds were tested in a pVASP cell-based assay, and for compounds with moderate permeability, good agreement was observed between the biochemical and functional assays. These compounds will function as efficient tools to further interrogate PKG1 alpha biology.